Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Weaning From Analgesia and Sedation in PICU
NCT03645603Phase 2Terminated
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Aug 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Substance Withdrawal Syndrome (SWS) comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: Change in Withdrawal Assessment Tool (WAT-1) scale. Started Aug 2018; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
Substance Withdrawal Syndrome (SWS)
Beyond the preview
Go deeper on NCT03645603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03645603.